Identification and Evaluation of Benzimidazole- Agonists of Innate Immune Receptor NOD2
Liora E. Wittle, Karl L. Ocius, Mahendra D. Chordia, Carly M. Van Wagoner, Timothy N. J. Bullock, Marcos M. Pires
The paper identifies benzimidazole compounds, including nocodazole, as NOD2 agonists with potential therapeutic benefits over existing MDP-based agonists.
ACS Infectious Diseases · Jan 13, 2026Peer-reviewedImmunology